Your browser is no longer supported. Please, upgrade your browser.
Settings
LOGC LogicBio Therapeutics, Inc. daily Stock Chart
LOGC [NASD]
LogicBio Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.84 Insider Own21.14% Shs Outstand23.18M Perf Week0.26%
Market Cap202.32M Forward P/E- EPS next Y-1.81 Insider Trans0.00% Shs Float16.72M Perf Month10.24%
Income-41.90M PEG- EPS next Q-0.48 Inst Own63.20% Short Float1.23% Perf Quarter7.67%
Sales1.00M P/S202.32 EPS this Y41.50% Inst Trans0.14% Short Ratio3.27 Perf Half Y-28.55%
Book/sh1.45 P/B5.42 EPS next Y1.60% ROA-69.90% Target Price- Perf Year-24.57%
Cash/sh1.68 P/C4.68 EPS next 5Y- ROE-87.00% 52W Range3.05 - 14.00 Perf YTD9.17%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-43.86% Beta-
Dividend %- Quick Ratio8.90 Sales past 5Y- Gross Margin- 52W Low157.70% ATR0.55
Employees41 Current Ratio8.90 Sales Q/Q- Oper. Margin- RSI (14)43.39 Volatility4.61% 6.40%
OptionableNo Debt/Eq0.29 EPS Q/Q-18.30% Profit Margin- Rel Volume0.64 Prev Close7.92
ShortableYes LT Debt/Eq0.29 Earnings- Payout- Avg Volume62.83K Price7.86
Recom1.50 SMA20-5.61% SMA50-1.80% SMA2002.35% Volume40,140 Change-0.76%
May-01-19Initiated ROTH Capital Buy $26
Jul-20-20 10:58AM  
Jun-05-20 07:00AM  
Jun-03-20 09:24PM  
May-28-20 07:00AM  
May-18-20 12:15PM  
11:56AM  
10:28AM  
May-17-20 07:45PM  
04:46PM  
02:23PM  
01:00PM  
May-16-20 03:05PM  
09:47AM  
May-15-20 01:25PM  
01:15PM  
12:54PM  
09:56AM  
09:46AM  
May-14-20 03:50PM  
01:00PM  
09:37AM  
May-13-20 08:40PM  
12:56PM  
09:51AM  
May-12-20 10:25PM  
02:15PM  
09:37AM  
08:17AM  
May-11-20 08:10PM  
04:10PM  
04:05PM  
12:53PM  
May-10-20 01:30PM  
12:20PM  
May-08-20 06:15PM  
May-07-20 03:15PM  
10:28AM  
May-06-20 04:50PM  
01:01PM  
May-05-20 07:45PM  
04:15PM  
May-04-20 01:55PM  
May-03-20 09:30AM  
May-01-20 06:15PM  
12:47PM  
Apr-30-20 05:37PM  
Apr-29-20 09:30PM  
08:05PM  
05:00PM  
Apr-28-20 11:00AM  
Apr-27-20 02:37PM  
Apr-25-20 03:45PM  
Apr-23-20 11:06PM  
Apr-22-20 10:29AM  
Apr-18-20 06:08PM  
Apr-15-20 09:35PM  
06:14PM  
04:15PM  
Apr-13-20 09:10PM  
Apr-12-20 01:20PM  
12:40PM  
Apr-10-20 12:22AM  
Apr-07-20 08:00PM  
05:20PM  
06:40AM  
Apr-06-20 10:32AM  
Apr-03-20 06:10AM  
Apr-02-20 03:06PM  
09:56AM  
Apr-01-20 07:27PM  
07:00PM  
Mar-31-20 10:00PM  
Mar-28-20 09:55PM  
11:41AM  
Mar-27-20 04:50PM  
01:17PM  
01:10PM  
10:01AM  
Mar-26-20 12:00PM  
Mar-25-20 06:30PM  
12:58PM  
10:01AM  
Mar-24-20 01:45PM  
10:00AM  
Mar-23-20 05:00PM  
01:30PM  
10:00AM  
Mar-21-20 08:50PM  
07:50PM  
03:00PM  
Mar-20-20 07:30PM  
03:00PM  
12:45PM  
12:14PM  
12:00PM  
Mar-19-20 08:02PM  
07:08PM  
04:41PM  
04:29PM  
01:08PM  
LogicBio Therapeutics, Inc., a genome editing company, focuses on developing medicines to treat rare diseases in patients with unmet medical need using GeneRide technology platform. The GeneRide technology is designed to integrate corrective genes into a patient's genome to provide a therapeutic effect. Its lead product candidate is LB-001 for the treatment of Methylmalonic Acidemia, a life-threatening disease that presents at birth. The company has a partnership with Children's Medical Research Institute to develop new viral vectors; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop new genome editing candidate Lb-301 for the treatment of crigler-najjar syndrome. LogicBio Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.